Pfizer Inc. on Friday said a Canadian federal court granted its request to prevent Novopharm Ltd. from launching a generic version of Pfizer's Lipitor cholesterol drug until a patent expires in July 2010.
The decision involving Lipitor, the world's top-selling drug, is subject to appeal, Pfizer said.
Subscribe via RSS
